CDASH

Introduction

CDASH: The Clinical Data Acquisition Standards Harmonization Implementation Guide (CDASHIG) establishes a standard way to collect data consistently across studies and sponsors so that data collection formats and structures provide clear traceability of submission data into the SDTM, delivering more transparency to regulators and others who conduct data review. The following videos introduce you to the CDASH model and the CDASHIG.


Versions

The latest versions of the Clinical Data Acquisition Standards Harmonization Implementation Guides (CDASHIGs) have been developed in reference to a specific CDASH model. However, the CDASH model is cumulative – each new release builds on the previous model. Therefore, the models are considered backward compatible.

Therapeutic Area User Guides

Therapeutic Area User Guides (TAUGs) extend the Foundational Standards to represent data that pertains to specific disease areas. TAUGs include disease-specific metadata, examples and guidance on implementing CDISC standards for a variety of uses, including global regulatory submissions. The following video will introduce you to TAUGs and how they relate to CDISC Foundational Standards.

Controlled Terminology

Controlled Terminology is the set of codelists and valid values used with data items within CDISC-defined datasets. The following video introduces you to CDISC Controlled Terminology and how it is used with CDISC standards.

Traceability

Traceability is a fundamental element of data quality and a requirement for studies submitted to regulatory authorities. From data collection to final analysis, traceability plays a crucial role in ensuring the integrity of source data and in reinforcing clinical research results. The following video provides an introduction to implementing traceability in CDISC-compliant studies.

Regulatory Requirements

CDISC standards are required or recommended by several global regulatory agencies. Standardized data enables regulators to streamline the review process with a more consistent use of analysis tools to better view drug data and highlight areas of concern. The following video introduces you to regulatory requirements and the use of CDISC standards.

Team Guiding Principles

Standards in Development

Foundational

For current versions of the standards, please visit the Standards Home Page.


Standard Sort descending Release Notes Projected Publication
ADaM Oncology Examples

Resolving Public Comments

2024
ADaM v3.0

In Development

2025
Analysis Results Standards v1.0

Public Review through 15 January

2024
CT Relationships for SDTM v1.7, SDTMIG v3.3, SDTMIG-MD v1.1

Resolving Public Review Comments

2024
SDTM for Observational Studies v1.0

Resolving Public Review Comments

2024
SDTM v2.1

Resolving Public Review Comments

Q2 2024
SDTM v2.2

In Development

2024
SDTMIG v4.0

In Development

2025
SENDIG v4.0

In Development

2024
Tobacco Implementation Guide v1.0

Resolving Public Review Comments

Q2 2024

Data Exchange

Therapeutic Areas

Knowledge Base